Timothy Garvey, MD, a professor of medicine at the University of Alabama at Birmingham
However, following a healthy diet and exercise regimen is recommended to maximize the benefits of the treatment
But its benefits could extend beyond weight lossin fact, new research shows semaglutide could lower peoples risk for adverse cardiac events by as much as 20%
By unraveling the complex interconnections between DPP-4, energy metabolism, and bone health, we can uncover valuable insight to guide the development of innovative treatments for conditions ranging from T2DM to osteoporosis
Both drugs are injected once per week
And here Zepbound holds an unfortunate special position: with an average of minus 20.9% on 15 mg in SURMOUNT-1, up to minus 22.5% over a longer course and even minus 26.6% in SURMOUNT-3, it achieves the greatest weight loss of any weight-management medication approved in the US